AI threatens enterprise-software loans; private credit tightens — JPMorgan Chase & Co. (JPM) watches

Private credit at a crossroads as AI reshapes software borrowers

Private credit markets face fresh stress as the arrival of more capable generative AI tools prompts lenders and banks, including large commercial lenders such as JPMorgan Chase, to reassess exposure to enterprise software borrowers. The launch of new models by Anthropic accelerates concerns that AI can supplant functions that many software vendors monetize, threatening cash flows on loans that have concentrated exposure to the sector since 2020. Market data show enterprise software is a major component of unitranche and other private loan structures and represents roughly 17% of U.S. BDC deal counts, making any structural revenue erosion material for a roughly $3 trillion private credit market.

Risk managers at banks and asset managers are scrutinising covenant strength, valuation assumptions and liquidity profiles of illiquid loan instruments that back leveraged buyouts and sponsor financings. Analysts and academics warn that many private credit portfolios are already stretched by liquidity shortfalls, loan extensions and tight refinancing windows; the potential for rapid adoption of AI-driven alternatives adds a new layer of default risk. UBS models cited by market participants suggest an aggressive disruption could lift U.S. private credit default rates materially above historical norms, a scenario that would have knock-on effects for bank balance sheets, syndication pipelines and secondary trading liquidity.

In response, lenders including large banks and private credit platforms are tightening underwriting, re-pricing risk and revisiting sector limits to control concentration. JPMorgan and peers are increasing surveillance of borrower KPIs tied to recurring revenue and customer retention metrics, while legal teams probe covenant adequacy for emerging product substitution risks. The development is also prompting stress testing of unitranche liquidity and the viability of covenant-lite structures, with sponsors and arrangers likely to face higher borrowing costs or reduced leverage if disruption scenarios become more probable.

Treasury flows, inflation indicators in focus

Macro markets reflect broader caution: futures show mixed trade, the 10-year Treasury yield edges up after reports China told some banks to limit U.S. Treasury holdings — a move JPMorgan warns could spur a “Sell America” dynamic — and the market awaits NY Fed inflation expectations, delayed payrolls and Friday’s CPI print.

Biotech partnering convenes ahead of J.P. Morgan week

Ahead of the J.P. Morgan 2026 meeting, the BIOSeedin Winter Innovation Partnering Summit meets in San Francisco, drawing pharma and investors to discuss dealmaking and globalisation strategies for oncology, cardio‑renal‑metabolic and autoimmune pipelines, underscoring continued capital‑for‑collaboration themes in healthcare financing.